Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] LIG D&A (079550) – Kiwoom Securities | Supply Shortage vs Rising Demand · Middle East Backlog · Haegung Expansion / 2026-04-30 Research
  • [IR] SK hynix (000660 / SKHY) – Q2 2026 Earnings Presentation / 2026-07-29 IR Room
  • [Research] ABL Bio (298380) – Yuanta Securities | Givastomig Efficacy · Bispecific ADC · Platform Valuation / 2026-01-29 Research
  • [Research] Hanwha Ocean (042660) – Yuanta | Merchant Mix Improvement · CPSP Project Value · MASGA Catalysts / 2026-07-06 Shipbuilding
  • [IR] Samsung Electro-Mechanics (009150) – Q4 2024 Earnings Presentation / 2025-01-24 IR Room
  • [Research] Alteogen (196170) – Shinhan Securities | First UK Patent Ruling Favors Merck · Positive Read-across to Global Disputes · Pipeline Out-Licensing Ahead / 2026-02-23 Research
  • [IR] Samsung Electronics (005930) – Q1 2025 Earnings Presentation / 2025-04-30 IR Room
  • [Research] SK hynix (000660 / SKHY) – DS Investment | Memory ASP · High-Value Product Mix · Supply Tightness / 2026-04-23 Research

[Research] Hanwha Ocean (042660) – Kiwoom | High-Price Mix · Merchant Margin Acceleration · 2H Order Intake / 2026-07-28

Posted on July 28, 2026August 22, 2026 By ksb220805@gmail.com

Brokerage : Kiwoom Securities

Analyst : Hangyeol Lee

Investment Rating : BUY (Maintained)

Target Price : KRW 144,000 (Maintained)

Core Momentum : Rapid merchant earnings expansion driven by the higher revenue mix of post-2024 high-price orders and structural cost reductions, with focus shifting to 2H order acceleration across merchant, naval, and offshore divisions

📊 1. [Valuation & Key Financial Metrics]

  • Rating & Target Price: BUY Maintained, Target Price maintained at KRW 144,000 (Current Price: KRW 88,800 as of July 27, 2026)
  • 2Q26 Earnings Summary: Revenue came in at KRW 5.44 trillion (+65.2% YoY) and Operating Profit reached KRW 736.1 billion (+98.0% YoY, OPM 13.5%), substantially beating consensus (KRW 533.5 billion) and the brokerage’s forecast (KRW 547.4 billion).
  • Key Forecast Financials (2025 → 2026F → 2027F):
    • Revenue: KRW 12.78 trillion → KRW 15.88 trillion (+24.2% YoY) → KRW 15.98 trillion
    • Operating Profit: KRW 1.17 trillion → KRW 2.21 trillion (+89.6% YoY, OPM 13.9%) → KRW 2.67 trillion
    • EBITDA: KRW 1.40 trillion → KRW 2.54 trillion → KRW 3.03 trillion
    • Net Profit (Controlling): KRW 1.25 trillion → KRW 1.88 trillion → KRW 1.98 trillion
    • EPS: KRW 4,066 → KRW 6,143 (+51.1% YoY) → KRW 6,460 (+5.2% YoY)
    • BPS (2026E): KRW 26,337
    • PER: 27.9x → 12.8x → 12.2x
    • PBR: 5.64x → 2.99x → 2.40x
    • ROE: 22.6% → 26.4% → 21.8%
    • Net Debt-to-Equity Ratio: 80.8% → 44.9% → 27.3%

🚀 2. [Market Opportunities & Business Outlook]

  • Merchant Division Margin Expansion: In 2Q26, the merchant shipbuilding division recorded revenue of KRW 3.24 trillion (+15% YoY, +16% QoQ) and operating profit of KRW 735.6 billion (+95% YoY, +47% QoQ, OPM 22.7%). Profitability accelerated sharply as high-price orders secured after 2024 made up over 70% of division revenue, aided by productivity gains, cost cuts, and favorable foreign exchange rates. As order prices in 2026 (for LNG carriers and VLCCs) remain 4–5% higher than 2025 levels, earnings growth is projected to continue through 2028.
  • Offshore & Naval Business Status: The offshore division achieved a slight operating turnaround due to the one-time revenue recognition of ~KRW 1.5 trillion from the P79 project. The naval (special ship) division continued to log operating losses due to fixed-cost burdens.
  • 2H Order Intake Requirements & Pipeline: Cumulative 1H26 merchant order intake reached 24 vessels (including 6 LNGCs and 15 VLCCs), necessitating additional order momentum in 2H to sustain annual capacity. A significant portion of 2029–2030 delivery slots for LNGCs is currently under negotiation, with order intake expected to expand as broader LNGC contracting gathers pace. For naval and offshore, active discussions are underway for domestic KDDX and Changbogo-N programs, US Navy RFI responses for combatants and auxiliary oilers, and various offshore tenders (FPSO, FLNG, WTIV).

📝 Editor’s Comment (Perspective)

The analyst views Hanwha Ocean as a shipbuilder demonstrating a rapid pace of fundamental earnings improvement in its merchant segment, supported by the swift revenue recognition of high-value order books and structural cost reductions. Beyond the immediate merchant margin surprise, this perspective places strategic emphasis on the need for follow-up order intake across merchant vessels, naval defense, and offshore projects in 2H to optimize annual production capacity and secure long-term revenue visibility.

To evaluate whether this investment thesis continues to materialize, key verification points include whether merchant operating margins remain elevated as 2024–2025 vintages expand in production, the conversion of 2029–2030 delivery slots into definitive LNGC contract awards, and concrete order gains in naval programs (including US Navy RFI outcomes and domestic programs) and offshore EPC tenders. These factors can be monitored through future quarterly earnings releases, official IR materials, regulatory filings, and periodic financial reports.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Shipbuilding

Post navigation

Previous Post: [Research] Hanwha Ocean (042660) – iM Securities | Merchant Profit Surprise · Special Ship Sentiment · Valuation De-rating / 2026-07-28
Next Post: [Research] Celltrion (068270) – DS Investment & Securities | 2Q26 Re: Steep Growth Exceeds Expectations · New Biosimilars Surge · Large-Cap Top Pick / 2026-07-28

Related Posts

  • [Research] LIG D&A (079550) – Kiwoom Securities | Expanding Order Opportunities · 1Q26 Earnings Beat · Global Air Defense Growth / 2026-05-08 Research
  • [Research] Hanwha Ocean (042660) – SK Securities | Merchant Margin Growth · Offshore Order Requirements · Global Naval Pipeline / 2026-07-13 Research
  • [Research] SK hynix (000660 / SKHY) – iM Securities | Memory ASP · Server Demand · Earnings Upgrades / 2026-03-31 Research
  • [Research] Hanwha Ocean (042660) – Shinhan | Merchant Profit Level-Up · Special Ship Order Variables · Balanced Portfolio / 2026-07-28 Research
  • [Research] Samsung SDI (006400) – IBK Securities | Accelerating North American ESS Conversions · FY26 AMPC KRW 359B · 4Q In Line / 2026-02-03 Research
  • [Research] Samsung Electro-Mechanics (009150) – Kyobo Securities | AI Server Demand · High-Value Mix · Structural Profitability / 2026-07-31 Research
  • [Research] SK hynix (000660 / SKHY) – Hanwha | LTA · HBM · Earnings Sustainability / 2026-04-24 Research
  • [Research] Samsung Electro-Mechanics (009150) – IBK Securities | CAPEX Surge · Foreign Inflows · Target Price Upgrade / 2026-07-16 Research
  • [IR] Samsung Electro-Mechanics (009150) – Q1 2026 Earnings Presentation / 2026-04-30 IR Room
  • [Research] Samsung Biologics (207940) – iM Securities | Annual Operating Profit Surpasses KRW 2T · Pure-CDMO Transition · Three-Pillar Growth Strategy / 2026-01-22 Research
  • [Research] LigaChem Biosciences (141080) – Eugene Investment & Securities | Pipeline Clinical Progression · Licensing Revenue · Earnings Turnaround / 2025-02-17 Research
  • [Research] SK hynix (000660 / SKHY) – Hana | Memory Pricing · Cash Flow · Shareholder Returns / 2026-01-30 Research
  • [Research] SK hynix (000660 / SKHY) – Eugene Investment | HBM Demand · AI Accelerator Diversification · Profitability / 2026-01-21 Research
  • [Research] SK hynix (000660 / SKHY) – IBK Securities | AI Servers · Full-Stack Memory · NAND Demand / 2026-04-24 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme